150 related articles for article (PubMed ID: 23265898)
1. Novel small molecule protein arginine deiminase 4 (PAD4) inhibitors.
Bozdag M; Dreker T; Henry C; Tosco P; Vallaro M; Fruttero R; Scozzafava A; Carta F; Supuran CT
Bioorg Med Chem Lett; 2013 Feb; 23(3):715-9. PubMed ID: 23265898
[TBL] [Abstract][Full Text] [Related]
2. Peptidomimetics as protein arginine deiminase 4 (PAD4) inhibitors.
Trabocchi A; Pala N; Krimmelbein I; Menchi G; Guarna A; Sechi M; Dreker T; Scozzafava A; Supuran CT; Carta F
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):466-71. PubMed ID: 25198885
[TBL] [Abstract][Full Text] [Related]
3. Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors.
Knuckley B; Luo Y; Thompson PR
Bioorg Med Chem; 2008 Jan; 16(2):739-45. PubMed ID: 17964793
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization.
Luo Y; Arita K; Bhatia M; Knuckley B; Lee YH; Stallcup MR; Sato M; Thompson PR
Biochemistry; 2006 Oct; 45(39):11727-36. PubMed ID: 17002273
[TBL] [Abstract][Full Text] [Related]
5. A fluoroacetamidine-based inactivator of protein arginine deiminase 4: design, synthesis, and in vitro and in vivo evaluation.
Luo Y; Knuckley B; Lee YH; Stallcup MR; Thompson PR
J Am Chem Soc; 2006 Feb; 128(4):1092-3. PubMed ID: 16433522
[TBL] [Abstract][Full Text] [Related]
6. Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis.
Kearney PL; Bhatia M; Jones NG; Yuan L; Glascock MC; Catchings KL; Yamada M; Thompson PR
Biochemistry; 2005 Aug; 44(31):10570-82. PubMed ID: 16060666
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a new class of inhibitors for the protein arginine deiminase type 4 (PAD4) by structure-based virtual screening.
Teo CY; Shave S; Chor AL; Salleh AB; Rahman MB; Walkinshaw MD; Tejo BA
BMC Bioinformatics; 2012; 13 Suppl 17(Suppl 17):S4. PubMed ID: 23282142
[TBL] [Abstract][Full Text] [Related]
8. Activity-based protein profiling reagents for protein arginine deiminase 4 (PAD4): synthesis and in vitro evaluation of a fluorescently labeled probe.
Luo Y; Knuckley B; Bhatia M; Pellechia PJ; Thompson PR
J Am Chem Soc; 2006 Nov; 128(45):14468-9. PubMed ID: 17090024
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation.
Lewis HD; Liddle J; Coote JE; Atkinson SJ; Barker MD; Bax BD; Bicker KL; Bingham RP; Campbell M; Chen YH; Chung CW; Craggs PD; Davis RP; Eberhard D; Joberty G; Lind KE; Locke K; Maller C; Martinod K; Patten C; Polyakova O; Rise CE; Rüdiger M; Sheppard RJ; Slade DJ; Thomas P; Thorpe J; Yao G; Drewes G; Wagner DD; Thompson PR; Prinjha RK; Wilson DM
Nat Chem Biol; 2015 Mar; 11(3):189-91. PubMed ID: 25622091
[TBL] [Abstract][Full Text] [Related]
10. Screening of natural inhibitors against peptidyl arginine deiminase 4 from herbal extracts by a high-performance liquid chromatography ultraviolet-visible based method.
Zhao J; Li Y; Gao C; Zhao Z; Zhang S; Dong J; Zuo H; Chen X; Xie B; Guo Z; Wang Y; Li H; Bian Y
J Chromatogr A; 2024 Feb; 1716():464643. PubMed ID: 38232639
[TBL] [Abstract][Full Text] [Related]
11. Novel furan-containing peptide-based inhibitors of protein arginine deiminase type IV (PAD4).
Teo CY; Tejo BA; Leow ATC; Salleh AB; Abdul Rahman MB
Chem Biol Drug Des; 2017 Dec; 90(6):1134-1146. PubMed ID: 28581157
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor.
Aliko A; Kamińska M; Falkowski K; Bielecka E; Benedyk-Machaczka M; Malicki S; Kozieł J; Wong A; Bryzek D; Kantyka T; Mydel P
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052493
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors.
Jones JE; Slack JL; Fang P; Zhang X; Subramanian V; Causey CP; Coonrod SA; Guo M; Thompson PR
ACS Chem Biol; 2012 Jan; 7(1):160-5. PubMed ID: 22004374
[TBL] [Abstract][Full Text] [Related]
14. Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential.
Jones JE; Causey CP; Knuckley B; Slack-Noyes JL; Thompson PR
Curr Opin Drug Discov Devel; 2009 Sep; 12(5):616-27. PubMed ID: 19736621
[TBL] [Abstract][Full Text] [Related]
15. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.
Knuckley B; Causey CP; Jones JE; Bhatia M; Dreyton CJ; Osborne TC; Takahara H; Thompson PR
Biochemistry; 2010 Jun; 49(23):4852-63. PubMed ID: 20469888
[TBL] [Abstract][Full Text] [Related]
16. Facile fluorescence-based detection of PAD4-mediated citrullination.
Wildeman E; Pires MM
Chembiochem; 2013 May; 14(8):963-7. PubMed ID: 23640867
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for Ca(2+)-induced activation of human PAD4.
Arita K; Hashimoto H; Shimizu T; Nakashima K; Yamada M; Sato M
Nat Struct Mol Biol; 2004 Aug; 11(8):777-83. PubMed ID: 15247907
[TBL] [Abstract][Full Text] [Related]
18. A fluopol-ABPP HTS assay to identify PAD inhibitors.
Knuckley B; Jones JE; Bachovchin DA; Slack J; Causey CP; Brown SJ; Rosen H; Cravatt BF; Thompson PR
Chem Commun (Camb); 2010 Oct; 46(38):7175-7. PubMed ID: 20740228
[TBL] [Abstract][Full Text] [Related]
19. PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis.
Koushik S; Joshi N; Nagaraju S; Mahmood S; Mudeenahally K; Padmavathy R; Jegatheesan SK; Mullangi R; Rajagopal S
Expert Opin Ther Targets; 2017 Apr; 21(4):433-447. PubMed ID: 28281906
[TBL] [Abstract][Full Text] [Related]
20. Development and use of clickable activity based protein profiling agents for protein arginine deiminase 4.
Slack JL; Causey CP; Luo Y; Thompson PR
ACS Chem Biol; 2011 May; 6(5):466-76. PubMed ID: 21265574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
